DR. PARESH D. PATEL MD NPI 1508022484

NPI Details

DR. Paresh D. Patel, MD is a pulmonary disease internal medicine in Houston, TX with 22 years of experience. The provider is an internist who treats diseases of the lungs and airways. The pulmonologist diagnoses and treats cancer, pneumonia, pleurisy, asthma, occupational and environmental diseases, bronchitis, sleep disorders, emphysema and other complex disorders of the lungs. DR. Paresh D. Patel, MD NPI is 1508022484. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

13325 HARGRAVE RD STE 265
HOUSTON, TX
ZIP 77070-190
Phone: (281) 870-4567
Fax: (281) 870-4884

The NPI 1508022484 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Test for allergy using allergenic extract (HCPCS:95004)
• Professional service for preparation and provision of single-dose vial of allergen (HCPCS:95144)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Management using the results of remote vital sign monitoring per calendar month, first 20 minutes (HCPCS:99457)
• Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days (HCPCS:99454)
• Collection and interpretation of physical parameters stored in computers and/or transmitted by the patient and/or caregiver to qualified health care professional, requiring 30 minutes or more, per 30 days (HCPCS:99091)
• Sleep study including heart rate, breathing, and sleep time (HCPCS:95800)
• Measurement of brain wave activity (eeg), awake and asleep (HCPCS:95819)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment (HCPCS:99453)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Evaluation of use of breathing device (HCPCS:94664)
• Test to examine how well the lungs exchange gases (HCPCS:94729)
• Test to measure rate of airflow (HCPCS:94375)
• Professional service for preparation and provision of 1 or more antigens (HCPCS:95165)
• Test to determine lung volumes using gas dilution or washout (HCPCS:94727)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Critical care, first 30-74 minutes (HCPCS:99291)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Test to measure expiratory airflow and volume (HCPCS:94010)
• Test to determine lung volumes using sensors (HCPCS:94726)
• Professional service for single injection of allergen (HCPCS:95115)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme (HCPCS:J7620)
• Test for exercise-induced lung stress (HCPCS:94618)
• Inhalation treatment for airway obstruction or sputum production (HCPCS:94640)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Test to measure expiratory airflow and volume changes before and after medication administration (HCPCS:94060)
• Professional service for multiple injections of allergen (HCPCS:95117)
• Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes (HCPCS:99458)
• Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted, for intramuscular use (HCPCS:91300)
• Sarscov2 vac 30 mcg trs-sucr (HCPCS:91305)
• Adm sarscov2 30mcg/0.3ml 3rd (HCPCS:0003A)
• Adm sarscv2 30mcg trs-sucr 3 (HCPCS:0053A)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Transitional care management services for problem of moderate complexity (HCPCS:99495)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)

The enumeration date for this NPI number is 7/31/2008 and was last updated on 10/18/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.